12:00 AM
Dec 04, 2000
 |  BC Week In Review  |  Clinical News  |  Regulatory

Neuropeptide Y regulatory update

Hormos received U.S. Patent No. 6,046,317 covering DNA encoding a leucine to proline mutation in the signal peptide...

Read the full 70 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >